^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

OlyCAR-019

i
Other names: OlyCAR-019, Anti-CD19 Autologous CAR-T Cell Infusion
Associations
Trials
Company:
920th Hospital of Joint Logistics Support Force of the Chinese People's Liberation Army
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
Associations
Trials
over1year
A Study of Novel Anti-CD19 CAR-T in Patients With r/r B-Cell Malignancies (clinicaltrials.gov)
P1/2, N=60, Recruiting, 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
New P1/2 trial
|
OlyCAR-019